NCT02647164View on ClinicalTrials.gov

The Value Of Circulating Tumor Cells In Patient With NSCLC In Postoperative Recurrence Monitoring

UnknownOBSERVATIONAL

Enrollment

360

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

September 30, 2018

Conditions

Non-small-cell Lung Carcinoma

Sponsors

Lead Sponsor

All Listed Sponsors

lead

GenoSaber

INDUSTRY